Howard W. Donnelly joined the AngioDynamics Board of Directors in March 2004 and is the President of Concert Medical LLC, a manufacturer of interventional medical devices. In addition, Mr. Donnelly is President and Chief Executive Officer of HydroCision Inc., a medical device manufacturer focused on the spine market. From 1999 to 2002, he was President of Level 1 Inc., a medical device manufacturer and a subsidiary of Smiths Group. From 1990-99, Mr. Donnelly was employed at Pfizer Inc., with his last position being Vice President, Business Planning and Development, for Pfizer's Medical Technology Group from 1997-99.
Eileen Auen most recently served as Executive Chairman of Helios, a $1.5 billion healthcare services firm formed by the merger of PMSI and Progressive Medical in 2013. Prior roles include Chairman and Chief Executive Officer of PMSI and Chief Executive Officer of APS, both healthcare services organizations. Earlier in her career she served as head of Healthcare Management at Aetna, president of HealthNet of the Northeast and president of Cigna’s southeast region. Ms. Auen earned a bachelor’s degree in economics and finance from Towson University, and an M.B.A. from the University of Virginia Darden School of Business. Ms. Auen currently serves as the Chairman of Point32 Health, a $10B healthplan serving the New England Region, the Lead Operating Director of Axia Women’s Health and a member of the board of directors at MedRisk, LLC. She is also a member of the board for Towson’s University Foundation and previously served on the Board of ICF (NASDAQ: ICFI) and Medstar Union Memorial Hospital.
Ms. Burgess was most recently Chief Financial Officer and Vice President of Finance for the Americas Region at Medtronic, Inc., a Fortune 200 global medical device company with more than $30 billion in annual revenues. Prior to this role, Ms. Burgess also served as Vice President of Customer Care for the Americas and Western Europe at Medtronic, Inc. and Vice President of Finance for the Cardiovascular Group’s Sales and Marketing function.
Ms. Burgess earned a Bachelor of Arts in Communication and Political Science from the University of Michigan and a Master’s in Business Administration from Ohio State University. Ms. Burgess is a member of the Board of Directors for Stepan Company.
Eric Honroth joined AngioDynamics as President and Chief Executive Officer in 2026, bringing more than 20 years of leadership experience in the medical device and life sciences industries.
Prior to joining AngioDynamics, Honroth served as Global President, Life Science at Getinge, where he held full P&L responsibility for an approximately $600 million global business with approximately 1,200 employees. In this role, he oversaw commercial operations, research and development, global manufacturing, innovation, quality and regulatory compliance, finance, and sustainability. Earlier at Getinge, he served as President for the North American Sales and Service division, leading the company's largest region managing 1,650 employees and $1.4 billion in revenue. Honroth was responsible for a diverse product portfolio spanning Cardiovascular, ECMO, Ventilation, major capital equipment, consumables, software, and service offerings.
Prior to Getinge, he held senior leadership positions at BD and Abbott. At BD, Honroth served as National Vice President of Sales for the Medical Surgical division. At Abbott, he served as General Manager of Abbott Vascular’s international Cardiology business in Canada, as well as Director of Sales for the Eastern Area in Endovascular and Senior Director of U.S. Commercial Operations and Strategic Planning. His experience spans cardiovascular, endovascular, urology, and life sciences markets across both U.S. and international businesses.
Honroth earned a Bachelor of Science degree from Miami University in Oxford, Ohio.
Wesley E. Johnson Jr. joined the Company's Board of Director's in January 2007. From 2003-07, Mr. Johnson served as a member of the board of RITA Medical Systems Inc. Since February 2008, Mr. Johnson has served as President, Chief Executive Officer and director of Cardiokinetix Inc., a developer of medical devices for the treatment of congestive heart failure. From October 2005 to February 2008 he served as General Manager of Abbott Spine S.A., a division of Abbott Laboratories. From June 2003 to October 2005, Mr. Johnson served as Division Vice President, Finance for Abbott Spine. From May 1999 to June 2003 he served as Vice President of Operations and Chief Financial Officer for Spinal Concepts. Mr. Johnson has a B.B.A. in accounting from Texas A&M University and became a Certified Public Accountant in 1981.
Karen Licitra joined the Company’s Board of Director’s in July 2019. From January 2014 through August 2015, Ms. Licitra served as Corporate Vice President, Worldwide Government Affairs & Policy at Johnson & Johnson, a medical device, pharmaceutical, and consumer packaged goods manufacturer. From December 2011 to December 2013, Ms. Licitra served as the Worldwide Chairman, Global Medical Solutions at Johnson & Johnson. From July 2002 to November 2011, she served as the Company Group Chairman and Worldwide Franchise Chairman at Ethicon Endo-Surgery, Inc., a Johnson & Johnson medical device company. From January 2001 to June 2002, she served as the President of Ethicon Endo-Surgery. Ms. Licitra has been a member of the board of directors of Si-Bone, Inc. (Nasdaq: SIBN) since August 2015. Ms. Licitra earned a Bachelor of Science degree in Commerce from Rider College.
In addition to her service on the AngioDynamics, Inc. (NASDAQ: ANGO) Board, Jan Reed serves as Chair of the Board of Directors and Chair of the Nominating and Governance Committee of AVITA Medical, Inc. (NASDAQ: RCEL; ASX: AVH), and as Lead Independent Director and Chair of the Nominating, Corporate Governance and Compliance Committee of Global Medical Response Solutions, Inc. (NYSE: GMRS). Previously, she served on the Board of Directors and as Chair of several Board Committees at Stepan Company (NYSE: SCL) from 2015 to 2026.
Prior to her board service, Ms. Reed held senior executive positions at several major corporations. She was Senior Vice President, General Counsel and Corporate Secretary of Walgreens Boots Alliance, Inc., a global pharmacy-led healthcare company, and Executive Vice President, Human Resources, General Counsel and Corporate Secretary of Solo Cup Company, where she had responsibility for the legal, human resources, internal audit, corporate communications and compliance functions. Earlier in her career, she served as Associate General Counsel, Corporate Secretary and Chief Corporate Governance Officer of Baxter International Inc.
Ms. Reed earned a Bachelor of Arts degree with honors in Psychology from the University of Michigan and a Juris Doctor from Northwestern University Pritzker School of Law.